AAAAAA

   
Results: 1-13 |
Results: 13
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Authors: Cleeman, JI Grundy, SM Becker, D Clark, LT Cooper, RS Denke, MA Howard, WJ Hunninghake, DB Illingworth, DR Luepker, RV McBride, P McKenney, JM Pasternak, RC Stone, NJ Van Horn, L Brewer, HB Ernst, ND Gordon, D Levy, D Rifkind, B Rossouw, JE Savage, P Haffner, SM Orloff, DG Proschan, MA Schwartz, JS Sempos, CT Shero, ST Murray, EZ
Citation: Ji. Cleeman et al., Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), J AM MED A, 285(19), 2001, pp. 2486-2497
HMG-CoA reductase inhibitors
Authors: Illingworth, DR Tobert, JA
Citation: Dr. Illingworth et Ja. Tobert, HMG-CoA reductase inhibitors, ADV PROTEIN, 56, 2001, pp. 77-114
Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipidsand colonic function
Authors: Jenkins, DJA Kendall, CWC Popovich, DG Vidgen, E Mehling, CC Vuksan, V Ransom, TPP Rao, AV Rosenberg-Zand, R Tariq, N Corey, P Jones, PJH Raeini, M Story, JA Furumoto, EJ Illingworth, DR Pappu, AS Connelly, PW
Citation: Dja. Jenkins et al., Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipidsand colonic function, METABOLISM, 50(4), 2001, pp. 494-503
Postprandial dyslipidemia: An atherogenic disorder common in patients withdiabetes mellitus
Authors: Ginsberg, HN Illingworth, DR
Citation: Hn. Ginsberg et Dr. Illingworth, Postprandial dyslipidemia: An atherogenic disorder common in patients withdiabetes mellitus, AM J CARD, 88(6A), 2001, pp. 9H-15H
Lipid-lowering drug therapy: more knowledge leads to more problems for composers of guidelines
Authors: Durrington, PN Illingworth, DR
Citation: Pn. Durrington et Dr. Illingworth, Lipid-lowering drug therapy: more knowledge leads to more problems for composers of guidelines, CURR OP LIP, 11(4), 2000, pp. 345-349
Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia
Authors: Ohashi, K Ishibashi, S Osuga, J Tozawa, R Harada, K Yahagi, N Shionoiri, F Iizuka, Y Tamura, Y Nagai, R Illingworth, DR Gotoda, T Yamada, N
Citation: K. Ohashi et al., Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia, J LIPID RES, 41(8), 2000, pp. 1199-1204
Inhibition of cholesterol synthesis by atorvastatin in homozygous familialhypercholesterolaemia
Authors: Raal, FJ Pappu, AS Illingworth, DR Pilcher, GJ Marais, AD Firth, JC Kotze, MJ Heinonen, TM Black, DM
Citation: Fj. Raal et al., Inhibition of cholesterol synthesis by atorvastatin in homozygous familialhypercholesterolaemia, ATHEROSCLER, 150(2), 2000, pp. 421-428
Dyslipidemia and atherosclerosis: how much more evidence do we need?
Authors: Illingworth, DR Durrington, PN
Citation: Dr. Illingworth et Pn. Durrington, Dyslipidemia and atherosclerosis: how much more evidence do we need?, CURR OP LIP, 10(5), 1999, pp. 383-386
Angiotensin-converting enzyme and cardiovascular disease risk
Authors: O'Malley, JP Maslen, CL Illingworth, DR
Citation: Jp. O'Malley et al., Angiotensin-converting enzyme and cardiovascular disease risk, CURR OP LIP, 10(5), 1999, pp. 407-415
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia - A randomized controlled trial
Authors: Stein, EA Illingworth, DR Kwiterovich, PO Liacouras, CA Siimes, MA Jacobson, MS Brewster, TG Hopkins, P Davidson, M Graham, K Arensman, F Knopp, RH DuJovne, C Williams, CL Isaacsohn, JL Jacobsen, CA Laskarzewski, PM Ames, S Gormley, GJ
Citation: Ea. Stein et al., Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia - A randomized controlled trial, J AM MED A, 281(2), 1999, pp. 137-144
Dual hepatic metabolism of cerivastatin-clarifications
Authors: Guyton, JR Dujovne, CA Illingworth, DR
Citation: Jr. Guyton et al., Dual hepatic metabolism of cerivastatin-clarifications, AM J CARD, 84(4), 1999, pp. 497-497
Cholesteryl ester hydrolase deficiency
Authors: Maslen, CL Illingworth, DR
Citation: Cl. Maslen et Dr. Illingworth, Cholesteryl ester hydrolase deficiency, LIPOPROTEINS IN HEALTH AND DISEASE, 1999, pp. 847-861
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
Authors: Illingworth, DR
Citation: Dr. Illingworth, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, LIPOPROTEINS IN HEALTH AND DISEASE, 1999, pp. 1161-1179
Risultati: 1-13 |